Rheumatology Gastroenterology interface: Co-managing IBD and AS

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on Rheumatology Gastroenterology interface: Co-managing IBD and AS
The interface between rheumatology and gastroenterology is crucial in co-managing conditions like inflammatory bowel disease (IBD) and ankylosing spondylitis (AS), which often coexist. Both are chronic, immune-mediated diseases with overlapping inflammatory pathways, making multidisciplinary care essential. Patients with AS frequently experience gastrointestinal symptoms, and those with IBD may develop inflammatory arthritis or axial spondyloarthritis, including AS.
Treatment strategies often require collaboration between rheumatologists and gastroenterologists to optimize care. Medications like TNF inhibitors and IL-17 blockers are effective for both conditions, targeting shared inflammatory mechanisms. However, treatment decisions must consider the disease activity in both systems, potential medication side effects, and individual patient needs. By working together, specialists can tailor therapies that manage both joint and gut inflammation, improving overall patient outcomes and quality of life.
Therefore, get an overall knowledge of rheumatology gastroenterology interface: co-managing IBD and AS
 

See More Webinars @ Hidoc Webinars